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1.  Introduction  
Non-steroidal anti-inflammatory drugs (NSAIDs) are 
known for anti-inflammatory effects and widely used 
for decades. Their function is due to inhibition of 
cyclooxygenase (COX) enzyme, which catalyzes the 
conversion of arachidonic acid (AA) to prostaglandins 
(PG) [1]. In 1989, two isoforms of cyclooxygenase 
were identified. Cyclooxygenase-1 (COX-1) or 
prostaglandin H1 synthase is present in many tissues 
and involved in many physiological processes, such as 
gastric cytoprotection, kidney function, and platelet 
aggregation. COX-2 or prostaglandin H2 synthase is 
expressed in tissues in response to inflammatory 




COX-2 inhibitory activities of some thiazinan, benzdiazinan, and benzthiazinan 
derivatives were modeled by quantitative structure–activity relationship (QSAR) with 
stepwise-multiple linear regression (SW-MLR) method.  
Methods and Results:  
The built model was robust and predictive with correlation coefficient (R
2
) of 0.840 for 
training and 0.522 for test groups. The quality of the model was evaluated by leave-one 
out (LOO) cross validation and LOO correlation coefficient (Q
2
) was 0.639. We also 
investigated a leverage approach for definition of applicability domain of model. 
According to QSAR model results, COX-2 inhibitory activity of selected data set had 
correlation with VE3_Dzm (Logarithmic coefficient sum of the last eigenvector from 
Barysz matrix weighted by mass), GATS6c (geometrical structure of the considered 
molecules in a complex way), and GATS5i (Geary autocorrelation of lag 5 weighted by 
ionization potential) descriptors derived from their structures. 
Conclusion: 
This study established a linear QSAR model for prediction of COX-2 inhibitory of 
thiazinan, benzthiazinan and benzdiazinan derivatives.  




Akbarpour Avini et al. QSAR modeling of COX-2 inhibitors  
Int Pharm Acta 
 
June 2018| Volume 1| Issue 2 |Article 4 
Page | 
191 
All classical NSAIDs, such as aspirin, ibuprofen, and 
indomethacin, are non-selective and inhibit both 
COX-1 and COX-2. Therefore, these drugs caused 
some adverse effects such as gastric ulceration and 
renal damage [3, 4]. It is believed that selective COX-
2 inhibitors provide anti-inflammatory effect, devoid 
of gastric and renal side effects, leading to an 
improved safety profile [5]. Subsequently, large 
efforts have been made to introduce selective COX-2 
inhibitors [6-9]. As documented, COX-2 is found up-
regulated in cancer cells and neurological disorders, 
such as Parkinson and Alzheimer’s diseases [10, 11]. 
Therefore, attempts to design and discovery of novel 
selective COX-2 inhibitors are essential and attractive 
in medicinal chemistry.  
In search for discovery of selective COX-2 inhibitors, 
several QSAR (quantitative structure–activity 
relationship) works have been carried out [12-14]. 
QSAR has been perceived as an approach to relate 
molecule structures to a wide variety of physical, 
chemical, biological, and technological properties. 
QSAR predicts that how chemical structure 
modifications can change proposed property, without 
experimental measurement. So development of a 
QSAR model reduces the cost of drug design and 
synthesis [15-17]. Major steps in constructing QSAR 
models include finding a data set of molecules, 
molecular descriptors calculation, variable selection, 
model building, and model validation. 
The purpose of the present study was to explore the 
significant structural features responsible for COX-2 
inhibitory activity of some thiazinan, benzdiazinan, 
and benzthiazinan derivatives which have been 
synthesized in our laboratory [18-20]. The results of 
in-vitro cyclooxygenase inhibition assays and 
molecular docking studies confirmed that thiazinan, 
benzdiazinan, and benzthiazinan scaffolds were 
capable of COX-2 inhibition (Figure 1). 
Consequently, QSAR analysis was carried out by 
multiple linear regressions (MLR) to model COX-2 
inhibitory activity of compounds with their structural 
features. 
 
Figure 1. (a) structure of COX-2 and (b) Compound 17 docked in the active site of murine COX-2 isozyme [18] 
2.  Materials and Methods 
2.1. Data set 
A set of 21 compounds bearing thiazinan, 
benzthiazinan, and benzdiazinan scaffolds which have 
been synthesized and evaluated as selective COX-2 
inhibitors in our laboratory was used as a data set 
searching for the QSAR model (18-20). All the 
biological data expressed as IC50 were converted into 
pIC50 (-log IC50) values. The total set of molecules 
was randomly separated into a training set (16 
compounds) for generating QSAR model and a test set 
(5 compounds) for validating the quality of the model. 
Selection of a training and test set molecules was done 
carefully such the that test set contains a range of low, 
moderate, and high activity compounds similar to the 
training set. The general chemical structures and 
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biological activity values of all of the compounds are 
shown in Table 1. 
 
Table 1. Chemical structures and the corresponding observed and predicted pIC50 values by SW-MLR method 
Compounds No 
R pIC50 
R1 R2 Exp. Pred. Res. 
 
1* Cl SO2Me 6.76 6.37 0.158 
2* F SO2Me 7.15 7.05 0.010 
3 H SO2Me 6.45 6.54 0.008 
4 Me SO2Me 7.00 6.94 0.002 
5 OMe SO2Me 7.15 7.02 0.017 
6* SO2Me Cl 6.65 6.85 0.037 
7* SO2Me F 7.04 7.06 0.000 
8 SO2Me H 6.92 6.90 0.000 
9 SO2Me Me 6.95 7.00 0.001 
10 SO2Me OMe 6.95 6.91 0.046 
 
11 Benzyl 7.15 7.14 0.000 
12 Phenyl 6.92 6.88 0.001 
13 Phenethyl 7.096 7.16 0.004 
14 4-F-phenyl 7.30 7.32 0.000 
15 4-Me-phenyl 7.22 7.11 0.012 
16 4-OMe-phenyl 6.95 7.12 0.026 
 
17* Benzyl 7.22 7.13 0.008 
18 Butyl 7.096 7.12 0.000 
19 Pentyl 7.096 7.15 0.002 
20 Phenethyl 7.15 7.08 0.004 
21 Propyl 6.95 6.94 0.000 
         *Test Set      
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2.2. Geometry optimization and molecular 
descriptor calculation  
The 3D chemical structures of the molecules were 
obtained using the HyperChem 7.0 software [21]. The 
initial optimization was conducted using the 
molecular mechanics force field (MM+) procedure 
included in HyperChem, and then semi-empirical 
method AM1 was applied to optimize the molecules’ 
geometry using the Polak-Ribiere algorithm until the 
root mean square gradient was 0.001 kcal mol-1. 
PaDEL [22] and Dragon [23] softwares were used to 
calculate the descriptors, and finally 2942 molecular 
descriptors were calculated. The calculated descriptors 
were first analyzed for the existence of constant or 
near constant (>90%) variables. The detected ones 
were then removed. Secondly, the descriptors’ 
correlation with each other and with the activity 
(pIC50) of the molecules was examined, and the 
collinear descriptors (i.e. correlation coefficient 
between descriptors is greater than 0.9) were detected. 
Among the collinear descriptors, the one exhibiting 
the highest correlation with the activity was retained, 
and the others were removed from the data matrix, 
and finally 320 descriptors were remained. 
3. Results 
Stepwise multiple linear regression (SW-MLR) 
method was applied to select the most important set of 
descriptors. Stepwise method is a combination of two 
strategies; forward selection and backward 
elimination. Stepwise regression performs multiple 
regression by adding or removing descriptors to 
improve the fitness of the model [24]. Figure 2 shows 
the results of SW-MLR process. To investigate the 
optimum number of descriptors to be used in the 
equation, the numbers of descriptors were plotted 
against regression coefficient, R2, and Standard Error 
of Estimate (SEE). As can be seen, R2 increases with 
the increasing number of descriptors, while the values 
of SEE decrease with the increasing number of 
descriptors. According to the rule of thumb, at least 
five compounds should be included in the equation for 
every descriptor. So, regarding the number of 
compounds in train set (16 compounds), R2, and SEE 
values, the most suitable model is three parametric 
one. 
The MLR analysis with a stepwise selection was 
carried out to relate the pIC50 to a three set of 
descriptors. Data analysis was performed by SPSS 
software (statistic version 17.0). It is described by the 
following equation 1: 
pIC50 = 8.07462(+/-0.42888) + 0.05657(+/-0.00786) 
VE3_Dzm - 1.3153(+/-0.33665) GATS5i +0.5073(+/-
0.22693) GATS6c     
 
Figure 2. Influences of the number of descriptors on 
the R
2
 and SEE of the regression model 
 
The built SW-MLR model produced good results and 
could predict the activity of train and test sets with R2 
= 0.840 and Rtest
2 = 0.522, respectively (Table 2). The 
predicted pIC50 values of the compounds in the 
training and test sets by SW-MLR model and 
residuals values (experimental pIC50 - predicted pIC50) 
are shown in Table 1. The plot of the predicted pIC50 
versus the experimental pIC50 obtained by the SW-
MLR modeling, is demonstrated in Figure 3. 
 
Table 2. Statistical parameters of SW-MLR model 
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Figure 3. The predicted pIC50 values by the SW-MLR 
modeling versus the experimental pIC50 values 
 
To validate the obtained model, the cross-validation 
analysis was performed using leave-one-out (LOO) 
method. For LOO cross-validation, one compound is 
removed from the train set, and the model is 
recalculated using the rest of the train set. The 
predicted activity for that point is then compared to its 
actual value. This is repeated until each data point is 
left off once. The cross-validated regression 
coefficient, Q2, was found as 0.639, and hence this 
model can be termed as statistically significant.  
The robustness of the resulting model was further 
validated by applying Y-randomization test. Several 
random shuffles were performed on dependent 
variable (pIC50), and new QSAR models were built. 
The low R2 and Q
2
LOO values show that the good 
results in the obtained model are regarded as 
reasonable and not because of a chance correlation 
(Table 3). 




LOO values of SW-MLR after 






1 0.104 -0.313 
2 0.075 -0.332 
3 0.091 -0.418 
4 0.148 -0.526 
5 0.198 -0.373 
6 0.080 -0.412 
7 0.280 -0.003 
8 0.181 -0.369 
9 0.117 -0.587 
10 0.124 -0.515 
 
The values of the selected descriptors of SW-MLR 
model are shown in Table 4. Collinearity is a major 
disadvantage in MLR models [25]. Therefore, the 
inter-correlation between the three selected descriptors 
in SW-MLR model was calculated (Table 5). The 
results from Table 5 showed that the correlation 
coefficient value of each pair descriptors was less than 
0.57; thus, the selected descriptors by stepwise 
method were completely independent. 
Table 4. The descriptors values were used in model 
construction. 
Name VE3_Dzm GATS5i GATS6c 
1 -19.738 0.813 0.952 
2 -12.370 0.617 0.963 
3 -16.214 0.797 0.867 
4 -9.897 0.814 0.990 
5 -7.657 0.823 0.912 
6 -7.804 0.859 0.684 
7 -7.258 0.708 0.649 
8 -7.799 0.853 0.780 
9 -6.666 0.829 0.780 
10 -5.747 0.873 0.612 
11 -4.074 0.894 0.934 
12 -9.132 0.845 0.871 
13 -2.635 0.940 0.940 
14 -6.961 0.644 0.977 
15 -6.248 0.856 1.017 
16 -5.111 0.861 0.922 
17 -3.728 0.899 0.890 
18 -2.455 0.932 0.821 
19 -1.931 0.976 0.924 
20 -2.936 0.951 0.847 
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Table 5. Correlation coefficient matrix of the selected 
descriptors by SW-MLR 
 VE3_Dzm GATS5i GATS6c 
VE3_Dzm 1 0.573 -0.158 
GATS5i  1 -0.136 
GATS6c   1 
After internal and external validation, it cannot be 
claimed that this QSAR model is reliable for unknown 
sample unless its domain of application is defined. If 
the predictive value of the sample falls into this 
applicability domain, the value may be considered 
reliable. The leverage along with the Williams plot is 
usually used to define applicability domain of a 
model. The Williams plot is definedas the plot of the 
standardized residuals versus the leverage (h). In this 
plot, two horizontal lines and one vertical line mark a 
safety area. Compounds with standard residuals >3 
standard deviation units and leverage higher than the 
warning h∗ are regarded as outliers. The leverage (hi) 
of every compound is calculated by the following 
equation: 
hi = xi (X
TX)-1xi
T 
In this equation, xi is the descriptor-row vector of the 
query molecule and X is the k × n matrix containing 
the k descriptor values for each one of the n training 
molecules. The critical leverage h* (the vertical line) 
is fixed at 3(k + 1)/n [26, 27]. From the Williams plot 
(Figure 4), it is obvious that all data points fall within 
the safety area in the model. All of the compounds 
have the leverage lower than the warning h∗ value of 
0.75. As a result, it can be said that the model is 
acceptable for prediction purpose. 
 
 
Figure 4. The William plot for the SW-MLR model 
 
4. Discussion and Conclusion 
The QSAR models provide some information about 
structural features influencing the biological activity 
of the studied compounds. Thus, interpretation of the 
descriptors appeared in the QSAR model could help to 
obtain some insight into the factors that are likely to 
have effects on the pIC50. According to the internal 
and external validation parameters, SW-MLR model 
possessed good fitting ability, good predictive ability, 
and high stability. The relative importance of the 
descriptors in the QSAR model was identified based 
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on their standardized regression coefficients. The 
calculated MLR coefficients cannot be used because 
the descriptors in the final MLR models have not the 
same units. Standardized regression coefficients of the 
selected descriptors in SW-MLR model are shown 
graphically in Figure 5. As can be seen, VE3-Dzm is 
more significant than the other descriptors with a 
positive sign. An explanation of the selected 
descriptors using handbook of molecular descriptors 
follows next [28, 29]. 
 
Figure 5. Standardized coefficients versus 
descriptor values in MLR 
 
VE3-Dzm refers to logarithmic coefficient sum of the 
last eigenvector from Barysz matrix weighted by 
mass. Another group of topological descriptors, used 
in DT models are those calculated from a Barysz 
matrix. The Barysz matrix is a weighted distance 
matrix that counts for the presence of heteroatoms and 
multiple bonds in a molecule [30]. This descriptor has 
a positive effect on the inhibitory activity. Hence, it is 
concluded that increasing the value of this descriptor 
causes an increase of COX-2 inhibitory activity. 
GATS6c is related to the geometrical structure of the 
considered molecules in a complex way. 
The Geary autocorrelation (GATS) is defined as [31]:  
 
GATS =
     ∑ ∑             
 
   
   ∑            
                                     
Where 𝟉 is the average value of atomic property wi 
over the molecule. The descriptors GATS6c is the 
Geary autocorrelations with lag k = 6 and the property 
w being the atomic charges. Since it presented a 
positive sign in MLR equation, increasein the value of 
this descriptor will lead to increase in the activity 
(pIC50). 
GATS5i displays Geary autocorrelation of lag 5 
weighted by ionization potential. In this descriptor, the 
Geary coefficient is a distance-type function, that 
function is any physicochemical property calculated 
for each atom of the molecule, such as atomic mass, 
polarizability, etc. The physicochemical property in 
this case is ionization potential [32]. As can be seen it 
has negative sign; therefore, increase in the GATS5i 
descriptor leads to decrease in pIC50 value.  
In summary, this study established a linear QSAR 
model for prediction of COX-2 inhibitory of 
thiazinan, benzthiazinan, and benzdiazinan 
derivatives. The model was validated using LOO 
cross-validation, Y-randomization, and external test 
set.  The built model had a good self- and external-
predictive power. The calculated applicability domain 
of the model showed that the obtained model was 
acceptable for prediction purpose. Based on QSAR 
models results, VE3-Dzm, GATS6c, and GATS5i were 
found to be important factors, controlling the COX-2 
inhibitory activity. 
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